Modern Chinese Medicine Group Co., Ltd. (Stock Code: 01643) announced that its Board of Directors will convene on 30 March 2026 (Monday). The meeting’s agenda includes:
• Approval of the audited annual results for the financial year ended 31 December 2025. • Consideration of a recommendation for a final dividend, if any.
The Board currently consists of six members: three executive directors—Sun Xinlei, Zhang Hongli and Jia Yanru—and three independent non-executive directors—Liu Ling, Leung Tsz Wing and Wong Chi Kin.
Any resolutions reached at the upcoming meeting, including potential dividend declarations, will be disclosed to the market after Board approval.